Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma

BACKGROUND: We retrospectively analyzed sunitinib outcome as a function of age in metastatic renal cell carcinoma (mRCC) patients. METHODS: Data were pooled from 1059 patients in six trials. Kaplan–Meier estimates of progression-free survival (PFS) and overall survival (OS) were compared by log-rank...

Descripción completa

Detalles Bibliográficos
Autores principales: Hutson, T E, Bukowski, R M, Rini, B I, Gore, M E, Larkin, J M, Figlin, R A, Barrios, C H, Escudier, B, Lin, X, Fly, K, Martell, B, Matczak, E, Motzer, R J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950861/
https://www.ncbi.nlm.nih.gov/pubmed/24434434
http://dx.doi.org/10.1038/bjc.2013.832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950861/
https://www.ncbi.nlm.nih.gov/pubmed/24434434
http://dx.doi.org/10.1038/bjc.2013.832

Ejemplares similares